Clera home
·Dashboard

Jobs at Parabilis Medicines (Now Hiring) — 6 open

Parabilis Medicines logoParabilis Medicines

Scientist I, De Novo Discovery and Screening

Cambridge, Massachusetts, United States · On-site

$110k–$130k/yr

Entry level$910M raised

About Parabilis Medicines Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets lon…

Skills: Phage Display, mRNA Display, Molecular Biology, Protein Engineering, Chemical Biology

Parabilis Medicines logoParabilis Medicines

Senior Manager, Financial Reporting

Cambridge, Massachusetts, United States · On-site

$140k–$170k/yr

Senior$910M raised

About Parabilis Medicines Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets lon…

Skills: U.S. GAAP, SEC Reporting, Technical Accounting, Internal Controls Over Financial Reporting, Financial Statement Preparation

Parabilis Medicines logoParabilis Medicines

Principal Scientist, Cell Pharmacology

Cambridge, Massachusetts, United States · On-site

$160k–$190k/yr

Senior+$835M raised

About Parabilis Medicines Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets lon…

Skills: Cell Pharmacology, High-Throughput Screening, Assay Development, Mammalian Cell Culture, CRISPR/RNAi

Parabilis Medicines logoParabilis Medicines

Vice President, New Product Planning

Cambridge, Massachusetts, United States · On-site

$315k–$345k/yr

Senior+$835M raised

About Parabilis Medicines Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets lon…

Skills: New Product Planning, Commercial Strategy, Portfolio Strategy, Market Analysis, Competitive Intelligence

Parabilis Medicines logoParabilis Medicines

Vice President, Biochemistry and Head of Early Discovery Projects

Cambridge, Massachusetts, United States · On-site

$310k–$340k/yr

Senior+$835M raised

About Parabilis Medicines Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets lon…

Skills: Protein Biochemistry, Biophysical Assays, Drug Discovery, Project Leadership, Strategic Planning

Parabilis Medicines logoParabilis Medicines

Scientist II, Assay Development & Screening

Cambridge, Massachusetts, United States · On-site

$120k–$145k/yr

Mid level$835M raised

About Parabilis Medicines Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets lon…

Skills: Assay Development, Biochemical Assays, Cell-Based Assays, Multiplexed Assays, SAR Determination

Parabilis Medicines logo

Scientist I, De Novo Discovery and Screening

Parabilis Medicines

Cambridge, Massachusetts, United States • On-site

Apply
Entry level

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

  • $110k–$130k/yr
  • Full-time
  • postgraduate degree
  • Annual Target Bonus, Equity, Comprehensive Suite Of Competitive Benefits
  • Posted 21d ago
  • ~40 hrs/week

Responsibilities

Design and execute high-throughput phage and mRNA display screening campaigns to discover novel binders for challenging protein targets. Develop and optimize display libraries and workflows while collaborating with cross-functional teams to advance discovery programs.

Requirements

Requires a PhD in Molecular Biology, Biochemistry, or a related field with 0-2 years of experience. Candidates must possess strong foundations in molecular biology techniques and experience with biochemical screening or display technologies.

Full job description

 

About Parabilis Medicines 

Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact. For more information, visit www.parabilismed.com or follow us on LinkedIn. 

What’s the opportunity?

We are seeking a highly motivated Scientist to join our Hit Discovery team and contribute to the advancement our Helicon Discovery Platform through the development and application of phage display and mRNA display technologies. This role is ideal for a recent PhD graduate or early-career scientist with a strong foundation in molecular biology, protein engineering, chemical biology, or a related discipline. The successful candidate will contribute to screening campaigns against previously “undruggable” protein targets, support the development and integration of noncanonical amino acids into mRNA display platform, and help innovate and optimize display screening workflows. This is an excellent opportunity to work in a fast-paced, highly collaborative environment focused on building next-generation discovery capabilities and discovering transformative therapeutics.

Key Responsibilities

  • Design, execute, and troubleshoot phage display and mRNA display high-throughput screening campaigns to discover novel binders against challenging protein targets.
  • Design, construct, and produce diverse phage and mRNA display libraries using standard and advanced molecular biology techniques, including PCR, cloning, and in vitro transcription/translation workflows.
  • Perform and optimize display selections, including library amplification, enrichment, and downstream characterization of hits.
  • Analyze screening outputs, including preparation of samples for sequencing and interpretation of sequencing data to guide decision-making.
  • Evaluate and implement new technologies, workflows, and process improvements, with a particular focus on enhancing the performance, robustness, and scalability of the mRNA display platform.
  • Collaborate closely with cross-functional teams, including data science, biochemistry, and assay development, to advance discovery programs.
  • Stay current with relevant literature and emerging screening technologies.

What you’ll need to be successful

  • PhD in Molecular Biology, Biochemistry, Chemical Biology, Bioengineering, or a related field, with 0-2 years of postdoctoral and/or industry experience.
  • Strong foundation in molecular biology techniques, including PCR, cloning, DNA/RNA handling, and DNA library construction.
  • Strong biochemical and screening experience; familiarity with display technologies (phage, yeast, ribosome, or mRNA display) is plus.
  • Experience with high-throughput screening workflows and laboratory automation is preferred.
  • Familiarity with next-generation sequencing workflows and basic data analysis is desirable.
  • Demonstrated ability to design and execute experiments independently, troubleshoot effectively, and interpret complex datasets.
  • Excellent organizational skills, attention to detail, and ability to manage multiple priorities in a fast-paced environment.
  • Strong written and verbal communication skills, with the ability to clearly present scientific data.
  • Collaborative mindset with a high degree of initiative, curiosity, and enthusiasm for platform innovation and drug discovery.

Core Values

Parabilis Medicines is a team of passionate pioneers who are trailblazing the future of precision medicine with the aim of making a meaningful difference in the lives of patients. The company is committed to promoting an inspiring and flourishing working environment for all employees across the business, in all departments, and driving innovation for patient benefit.

  • Growth-Minded. We’re inventing a new class of medicines—one applicable to therapeutic targets that have been dreamt about, but always considered impossible to drug. Our work requires us to be curious, humble and adaptable.
  • In(ter)dependent. We are fiercely independent as a leader in defying the limitations of current therapeutic modalities, and interdependent as a team as we work collaboratively to shift drug discovery paradigms and provide patients with better treatment options.
  • Patient-focused. We are deeply focused on patient outcomes, and all energy in the company is focused on science as it translates to patient impact.
  • All-In. We’re All-In on solving some of the hardest scientific challenges and delivering one of the most effective new classes of drugs in history.

The base salary range for this position is $110,000-$130,000, depending on experience, qualifications, and internal practices. Parabilis’s total compensation package also includes an annual target bonus, equity, and a comprehensive suite of competitive benefits designed to support our employees’ overall well-being.

As an equal opportunity employer, Parabilis Medicines values an inclusive workplace and welcomes applicants of all backgrounds and experiences. All qualified applicants will receive consideration for employment without discrimination on the basis of race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability, or any other factors prohibited by law.

30 Acorn Park Drive    |     Cambridge, MA 02140    |    www.parabilismed.com

Related keywords

De Novo DiscoveryHeliconsAlpha-Helical PeptidesWnt/β-catenin PathwayZolucatetidePhage DisplaymRNA DisplayMolecular BiologyProtein EngineeringChemical BiologyPCRCloningIn Vitro TranslationHigh-Throughput ScreeningNext-Generation SequencingDNA Library Construction

About Parabilis Medicines

LinkedInVisit site

We are dedicated to creating extraordinary medicines for people affected by serious diseases

Industry
Biotechnology Research
Company size
51-200 employees
Founded
2016
Headquarters
Cambridge, MA
LinkedIn followers
19,070
Total funding
$910M

Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact.

Offices: 30 Acorn Park Dr, Cambridge, MA 02140, US

Health CareBiopharmaBiotechnologyLife ScienceMedicalPrecision MedicinePharmaceutical
View all jobs at Parabilis Medicines

About Parabilis Medicines

LinkedInVisit site

We are dedicated to creating extraordinary medicines for people affected by serious diseases

Industry
Biotechnology Research
Company size
51-200 employees
Founded
2016
Headquarters
Cambridge, MA
LinkedIn followers
19,070
Total funding
$910M

Parabilis Medicines™ is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact.

Offices: 30 Acorn Park Dr, Cambridge, MA 02140, US

Health CareBiopharmaBiotechnologyLife ScienceMedicalPrecision MedicinePharmaceutical
View all jobs at Parabilis Medicines

Similar companies hiring

Thermo Fisher Scientific (2289)Roche (1155)CSL (962)Amgen (863)ICON plc (733)Syneos Health (399)Mineralys Therapeutics, Inc. (314)Fortrea (254)Agilent Technologies (241)Gilead Sciences (200)BeiGene (167)Genentech (163)
Clera home

Your AI-talent agent. Connecting talents with dream jobs.

Earn $5,000

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

Tools

  • Salary Calculator
  • Resume Review
  • Startup Map

Explore

  • Jobs
  • Discover Jobs
  • Companies
  • Referral

Platform

  • Pricing
  • Integrations
  • Partners
  • Acquihire

Clera

  • Manifesto
  • Engineering
  • We are hiring!
  • FAQs
  • Blog
  • Press

© 2026 Clera Labs, Inc.

PrivacyTermsBug Bounty